Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume 32, Issue 9, Pages 1309-1315Publisher
PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-009-1917-3
Keywords
EGCG; Cervical cancer; HPV; ER; Aromatase
Categories
Funding
- Beijing Municipal Commission of Education [KM200810025015]
Ask authors/readers for more resources
EGCG [(-)-epigallocatechin-3-gallate] has shown its antitumor ability and perhaps a potential regimen for cancer patients. The goal of this study was to investigate the effect of EGCG on human papilloma virus (HPV) positive cervical cancer cell lines. EGCG inhibited the growth of CaSki (HPV16 positive) and HeLa (HPV18 positive) cells in a time- and concentration-dependent manner. Cell cycle arrest and apoptosis were observed in two cell lines after EGCG exposure. More importantly, we focused on EGCG regulation ability on pivotal genes involved in cervical cancer: viral oncogenes E6/E7, estrogen receptor (ER) and aromatase. Our results suggested that EGCG may be suitable for prevention and treatment of cervical cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available